Fundraising FoxNorth South Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
BiotechDeep TechDigital HealthHealthtechSan Francisco, US
Prof. Dustin(Co-founder)Ashwin Nandakumar(Founder)inAshwin Jainarayanan(Founder)inAshwin Menon Nandakumar(Founder)in
Co-investorsFelicis VenturesMetaplanetOxonian VenturesRitual CapitalY CombinatorOxford Angel Fund+4 more
ResistanceBio develops treatments to address drug resistance in cancer patients.
BiotechHealthtechSan Francisco, US
Nicholas Goldner(CEO/Founder)inChristopher Bulow(Founder)inKYLE LAPHAM(Executive Officer, Director)
BoardOMRI AMIRAV-DRORY(Director)in
Co-investorsFifty YearsY CombinatorAlumni VenturesAsymmetry VenturesBrightstone Venture CapitalCantos Ventures+10 more
Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.
AI & Machine LearningBiotechDeep TechHealthtechSeattle, US
Alex Federation(Founder)inLindsay Pino(Founder)inAlex Federation, Ph.D.(Chief Executive Officer & Co-Founder)Lindsay Pino, Ph.D.(Chief Technology Officer & Co-Founder)
BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in
Co-investorsFarvatn VentureFifty YearsFundersClubJude GomilaNFXTwo Bear Capital+9 more
Tiny Health offers at-home gut and vaginal microbiome test kits with age-specific, evidence-based reports that recommend diet, supplement, and lifestyle changes.
Digital HealthHealthtechWellness & Fitness
Cheryl Sew Hoy(Founder)in
Co-investorsAlumni VenturesB Capital GroupB4 CapitalCartan CapitalModi VenturesNext Coast Ventures+11 more
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.